intuicor 50 mg/7,5 mg
anpharm przedsiebiorstwo farmaceutyczne s.a., poľsko - metoprolol a ivabradín - 41 - cardiaca
intuicor 25 mg/7,5 mg
anpharm przedsiebiorstwo farmaceutyczne s.a., poľsko - metoprolol a ivabradín - 41 - cardiaca
intuicor 50 mg/5 mg
anpharm przedsiebiorstwo farmaceutyczne s.a., poľsko - metoprolol a ivabradín - 41 - cardiaca
intuicor 25 mg/5 mg
anpharm przedsiebiorstwo farmaceutyczne s.a., poľsko - metoprolol a ivabradín - 41 - cardiaca
lumeblue (previously known as methylthioninium chloride cosmo)
alfasigma s.p.a. - metyltioníniumchlorid - colorectal neoplasms; colonoscopy - other diagnostic agents - lumeblue is indicated as a diagnostic agent enhancing visualisation of colorectal lesions in adult patients undergoing screening or surveillance colonoscopy.
tecartus
kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - lymfóm, mantle-cell - antineoplastické činidlá - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).
metoprolol medreg 50 mg
medreg s.r.o., Česká republika - metoprolol - 58 - hypotensiva
metoprolol medreg 100 mg
medreg s.r.o., Česká republika - metoprolol - 58 - hypotensiva
carvykti
janssen-cilag international nv - ciltacabtagene autoleucel - viacnásobný myelóm - carvykti is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.
zonisamide neuraxpharm 300 mg tablety
neuraxpharm bohemia s.r.o., Česká republika - zonisamid - 21 - antiepileptica, anticonvulsiva